SynthesisBMC cardiovascular disorders2025
Dyslipidemia and associated factors among hypertensive patients in Ethiopia: a systematic review and meta-analysis.
Synthesis in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDyslipidemia and other CVD risk factors in cardiac patients can lead to accelerated atherosclerosis, morbidity, and significant mortality. Identifying the potential contributory factors of dyslipidemia in hypertensive patients is crucial in order to manage the disease condition and reduce further complications. Although dyslipidemia has been studied in many countries, evidence of pooled prevalence and its risk factors in Ethiopia remains scarce. Thus, this meta-analysis aimed to estimate the pooled prevalence of dyslipidemia (high TG, low HDL-C, high LDL-C, and high TC) and associated factors among adults with hypertension in Ethiopia.
methodsThe reporting system adhered to the Preferred Reporting Items for Systematic Review and Meta-analysis guidelines. Articles were searched using electronic databases such as PubMed, Cochrane Library, Science Direct, African Journals Online, and Google Scholar from April 1 to April 21, 2024 to find relevant studies. We utilized Endnote X7 and STATA 11 for bibliographical management and statistical analysis, respectively. The heterogeneity of the included studies was analyzed using forest plots, Cochran's Q statistics, I² test, and P-values.
resultsThe electronic searches yielded 10,629 articles. Based on the quality assessment, all the included studies had high quality. The overall pooled prevalence of dyslipidemia among hypertensive patients in Ethiopia was 37.12% (95% CI: 31.79-42.44%; I²=98.4%). The pooled point estimates for high TC were (33.39%, 95% CI: 23.92-42.85; I²=97.9%), TG (38.89%, 95% CI: 32.90-44.88; I²=93.6%), high LDL-c (33.98%, 95% CI: 21.46-46.49; I²=98.4%), and low HDL-c (42.23%, 95% CI: 28.76-55.71; I²=98.9%). Based on this meta-analysis, dyslipidemia was associated with age ≥ 40 years and sedentary lifestyle.
conclusionThis study suggests that dyslipidemia was high among the study participants, which underlines urgent need for early detection and public health interventions through the integrated involvement of public, governmental, and non-governmental organizations. Dyslipidemia was associated with, age ≥ 40 years, and sedentary lifestyle. This alarms the need for lipid profile assessment for patients periodically, with treatment follow-up to monitor any rising patterns and cardiovascular related risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.